MMS Holdings Inc, founded in 2005 and headquartered in Canton, Michigan, is a leading global provider of data management and regulatory submission services for the pharmaceutical and biotechnology industries. The company’s primary offerings include clinical trial data management, medical writing, and regulatory consulting, all aimed at facilitating efficient drug development processes.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| PUBFP 1.25% 2028-06-13 EURMMS Holdings Inc | United States | 2028-06-13 | 1.250 | 2.60 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
MMS Holdings began issuing bonds in 2018, with a notable corporate action in 2021 when it launched a $50 million bond offering to fund expansion into new markets. This issuance had a competitive yield of 4.5%, aligning favorably with the industry average of 5.0%. In 2023, MMS Holdings also introduced a unique callable feature on its bonds, allowing for greater flexibility in managing debt as market conditions evolve.